The role of cathepsin K in oral and maxillofacial disorders
- PMID: 26458004
- DOI: 10.1111/odi.12378
The role of cathepsin K in oral and maxillofacial disorders
Abstract
Cathepsin K (CTSK) was thought to be a collagenase, specifically expressed by osteoclasts, and played an important role in bone resorption. However, more and more research found that CTSK was expressed in more extensive cells, tissues, and organs. It may not only participate in regulating human physiological activity, but also be closely related to a variety of disease. In this review, we highlight the relationship between CTSK and oral and maxillofacial disorders on the following three aspects: oral and maxillofacial abnormities in patients with pycnodysostosis caused by CTSK mutations, oral and maxillofacial abnormities in Ctsk(-/-) mice, and the role of CTSK in oral and maxillofacial diseases, including periodontitis, peri-implantitis, tooth movement, oral and maxillofacial tumor, root resorption, and periapical disease.
Keywords: cathepsin K; periapical diseases; periodontitis; pycnodysostosis; root resorption; tooth movement.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011.Orphanet J Rare Dis. 2011 May 10;6:20. doi: 10.1186/1750-1172-6-20. Orphanet J Rare Dis. 2011. PMID: 21569238 Free PMC article. Review.
-
Not all pycnodysostosis-related mutants of human cathepsin K are inactive - crystal structure and biochemical studies of an active mutant I249T.FEBS J. 2018 Nov;285(22):4265-4280. doi: 10.1111/febs.14655. Epub 2018 Sep 26. FEBS J. 2018. PMID: 30199612
-
Novel CTSK mutation resulting in an entire exon 2 skipping in a Thai girl with pycnodysostosis.Pediatr Int. 2013 Oct;55(5):651-5. doi: 10.1111/ped.12091. Pediatr Int. 2013. PMID: 24134756
-
Dental Abnormalities Caused by Novel Compound Heterozygous CTSK Mutations.J Dent Res. 2015 May;94(5):674-81. doi: 10.1177/0022034515573964. Epub 2015 Mar 2. J Dent Res. 2015. PMID: 25731711 Free PMC article.
-
Pycnodysostosis: a case series of eight Saudi patients with cathepsin K gene mutation and a literature review.Front Endocrinol (Lausanne). 2025 Apr 17;16:1517840. doi: 10.3389/fendo.2025.1517840. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40313484 Free PMC article. Review.
Cited by
-
Treatment with an inhibitor of matrix metalloproteinase 9 or cathepsin K lengthens embryonic lower jaw bone.Orthod Craniofac Res. 2023 Aug;26(3):500-509. doi: 10.1111/ocr.12635. Epub 2023 Feb 1. Orthod Craniofac Res. 2023. PMID: 36680416 Free PMC article.
-
[Activation of mir-30a-wnt/β-catenin signaling pathway upregulates cathepsin K expression to promote cementogenic differentiation of periodontal ligament stem cells].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Oct 20;41(10):1439-1447. doi: 10.12122/j.issn.1673-4254.2021.10.01. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 34755658 Free PMC article. Chinese.
-
Clinical and radiographic features of pycnodysostosis: A case report.J Clin Exp Dent. 2017 Oct 1;9(10):e1276-e1281. doi: 10.4317/jced.54105. eCollection 2017 Oct. J Clin Exp Dent. 2017. PMID: 29167721 Free PMC article.
-
Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway.Heliyon. 2023 Jun 29;9(7):e17841. doi: 10.1016/j.heliyon.2023.e17841. eCollection 2023 Jul. Heliyon. 2023. PMID: 37539209 Free PMC article.
-
A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy.Front Pharmacol. 2022 Oct 26;13:1046451. doi: 10.3389/fphar.2022.1046451. eCollection 2022. Front Pharmacol. 2022. PMID: 36386169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical